US · Healthcare

ANI Pharmaceuticals Inc (ANIP)

Drug Manufacturers - Specialty & Generic

ANI Pharmaceuticals Inc (ANIP) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ANIP

P/E ratio

18.00

ANI Pharmaceuticals Inc (ANIP) — FAQ

What is ANIP's P/E ratio?

The price-to-earnings (P/E) ratio for ANI Pharmaceuticals Inc (ANIP) is 18.00 (data as of 2026-03-23).

Does ANI Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for ANI Pharmaceuticals Inc (ANIP). Check the MyAverix Finance app for the latest dividend data.

What sector is ANI Pharmaceuticals Inc in?

ANI Pharmaceuticals Inc (ANIP) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ANIP listed on?

ANIP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)